Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert L. Rosiello currently holds 7,508 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert L. Rosiello has been a net buyer of VRX stock. They have purchased $5.0M and sold $0 worth of shares.
Robert L. Rosiello's most recent insider trade was on Jul 1, 2026, when they sold 7,508 shares at $0.00 per share.
Robert L. Rosiello serves as Executive at Valeant Pharmaceuticals International, Inc. (VRX). They have executed 13 insider transactions totaling $5.0M over their tenure at the company.
Robert L. Rosiello holds the position of Executive at Valeant Pharmaceuticals International, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Robert L. Rosiello has shown a buying trading pattern, with $5.0M in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Robert L. Rosiello was on Jun 12, 2015, when they purchased $3.0M worth of VRX shares. This transaction involved 12,900 shares at $232.51 per share.
Robert L. Rosiello currently owns 7,508 shares of Valeant Pharmaceuticals International, Inc. (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert L. Rosiello's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert L. Rosiello has 13 Form 4 filings on record as an insider at Valeant Pharmaceuticals International, Inc..
Set alerts for Robert L. Rosiello and 40,000+ other insiders.